ConductScience.org, home

Comparison · NCT03287830-16873cf5

Intervention vs Usual Care: Percentage of Participants Who Receive Influenza Vaccination by April 30 Each Year

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Intervention vs Usual Care: Percentage of Participants Who Receive Influenza Vaccination by April 30 Each Year. Trial comparisons, record NCT03287830-16873cf5. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT03287830-16873cf5

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.8380.8150.859wilson
Risk in group 20.8090.7840.832wilson
Risk difference, group 1 minus group 20.0291-0.003640.0618newcombe hybrid score
Risk ratio, group 1 over group 21.040.9961.08log
Odds ratio, group 1 over group 21.220.9751.53log
Number needed to treat, for one more participant with the outcome on Intervention than on Usual Care34.4from the risk difference intervalthe interval includes no difference

Groups2

Group 2 names the comparator: usual care.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1InterventionText message influenza vaccine reminders~Text message influenza vaccine reminders: Text message reminders for second dose of influenza vaccination8751,044OG000
Group 2Usual Care
Season 2017-18: Usual care has no text message~Season 2018-19: Usual care includes on text message with a link to American Academy of Pediatrics parenting information page. The purpose is to provide those randomized to usual care with tangible benefit that is not related to the study.
8431,042OG001

Outcome

Type
PRIMARY
Title
Percentage of Participants Who Receive Influenza Vaccination by April 30 Each Year
Description
Receipt of second dose influenza vaccine by the end of flu season, which is April 30 each year
Time frame
Up to receipt of second dose, an average of 6 months
Population

Source ClinicalTrials.gov

Trial

Title
Flu2Text: Text Message Reminders for 2nd Dose of Influenza Vaccine
NCT number
NCT03287830
Phases
NA
Conditions
Influenza, Vaccination
Interventions
Text message influenza vaccine reminders
Lead sponsor
Columbia University
Results first posted
2023-03-14

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT03287830-16873cf5